{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:51Z","timestamp":1792785051863,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":93,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhangzhou Health Vocational College Natural Science Foundation","award":["ZWYZ202308"],"award-info":[{"award-number":["ZWYZ202308"]}],"id":[{"id":"https:\/\/ror.org\/02s4z5j43","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Zhangzhou Natural Science Foundation","award":["ZZ2023J44"],"award-info":[{"award-number":["ZZ2023J44"]}]},{"name":"Scientiffc Research Foundation for Advanced Talents of Zhangzhou Health Vocational College","award":["BSKYQD-6"],"award-info":[{"award-number":["BSKYQD-6"]}],"id":[{"id":"https:\/\/ror.org\/02s4z5j43","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-60728-y","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:02:02Z","timestamp":1783526522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Total flavonoids from Ageratum conyzoides synergize with docetaxel to induce ferroptosis in prostate cancer cells via the NRF2\/SLC7A11\/GPX4 signaling pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Huili","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"60728_CR1","doi-asserted-by":"publisher","first-page":"853623","DOI":"10.3389\/fendo.2022.853623","volume":"13","author":"FQ Wang","year":"2022","unstructured":"Wang, F. Q. et al. Burden of Prostate Cancer in China, 1990\u20132019: Findings From the 2019 Global Burdenof Disease Study. Front. Endocrino. 13, 853623. https:\/\/doi.org\/10.3389\/fendo.2022.853623 (2022).","journal-title":"Front. Endocrino"},{"issue":"6","key":"60728_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3322\/caac.70028","volume":"75","author":"B Tyler","year":"2025","unstructured":"Tyler, B. et al. Prostate cancer statistics, 2025. CA Cancer J. Clin. 75 (6), 485\u2013497. https:\/\/doi.org\/10.3322\/caac.70028 (2025).","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"60728_CR3","doi-asserted-by":"publisher","first-page":"104384","DOI":"10.1016\/j.drudis.2025.104384","volume":"30","author":"SX Zhang","year":"2025","unstructured":"Zhang, S. X., Zhang, T., Kinsella, G. K. & Curtin, J. F. A review of the efficacy of prostate cancer therapies against castration-resistant prostate cancer. Drug Discov Today. 30 (6), 104384. https:\/\/doi.org\/10.1016\/j.drudis.2025.104384 (2025).","journal-title":"Drug Discov Today"},{"issue":"5","key":"60728_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.eururo.2025.06.013","volume":"88","author":"A Cimadamore","year":"2025","unstructured":"Cimadamore, A., Boixareu, C., Sharp, A., Beltran, H. & de Bono, J. S. Novel Therapeutic Strategies for Metastatic Prostate Cancer Care. Eur. Urol. 88 (5), 437\u2013448. https:\/\/doi.org\/10.1016\/j.eururo.2025.06.013 (2025).","journal-title":"Eur. Urol."},{"issue":"23","key":"60728_CR5","doi-asserted-by":"publisher","first-page":"11665","DOI":"10.3390\/ijms262311665","volume":"26","author":"R Cicchetti","year":"2025","unstructured":"Cicchetti, R. et al. J. Mol. Sci. 26(23), 11665. https:\/\/doi.org\/10.3390\/ijms262311665. (2025).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"60728_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.eururo.2020.09.046","volume":"79","author":"P Cornford","year":"2025","unstructured":"Cornford, P. et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur. Urol. 79 (2), 263\u2013282. https:\/\/doi.org\/10.1016\/j.eururo.2020.09.046 (2025).","journal-title":"Eur. Urol."},{"issue":"4","key":"60728_CR7","doi-asserted-by":"publisher","first-page":"e141335","DOI":"10.1172\/JCI141335","volume":"131","author":"S Lv","year":"2021","unstructured":"Lv, S. et al. Regulation and targeting of androgen receptor nuclear localization in castration-resistant prostate cancer. J. Clin. Invest. 131 (4), e141335. https:\/\/doi.org\/10.1172\/JCI141335 (2021).","journal-title":"J. Clin. Invest."},{"issue":"15","key":"60728_CR8","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1056\/NEJMoa040720","volume":"351","author":"IF Tannock","year":"2004","unstructured":"Tannock, I. F. et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl. J. Med. 351 (15), 1502\u20131512. https:\/\/doi.org\/10.1056\/NEJMoa040720 (2004).","journal-title":"N Engl. J. Med."},{"issue":"2","key":"60728_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1200\/JCO.2007.12.4008","volume":"26","author":"DR Berthold","year":"2008","unstructured":"Berthold, D. R. et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study. J. Clin. Oncol. 26 (2), 242\u2013245. https:\/\/doi.org\/10.1200\/JCO.2007.12.4008 (2008).","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"60728_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2018.09.035","volume":"175","author":"MF Sanmamed","year":"2018","unstructured":"Sanmamed, M. F. & Chen, L. P. A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization. Cell 175 (2), 313\u2013326. https:\/\/doi.org\/10.1016\/j.cell.2018.09.035 (2018).","journal-title":"Cell"},{"issue":"10031","key":"60728_CR11","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","volume":"387","author":"JE Rosenberg","year":"2016","unstructured":"Rosenberg, J. E. et al. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. Lancet 387 (10031), 1909\u20131920. https:\/\/doi.org\/10.1016\/S0140-6736(16)00561-4 (2016).","journal-title":"Lancet"},{"issue":"1","key":"60728_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1200\/JCO.2016.69.1584","volume":"35","author":"TM Beer","year":"2017","unstructured":"Beer, T. M. et al. Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer. J. Clin. Oncol. 35 (1), 40\u201347. https:\/\/doi.org\/10.1200\/JCO.2016.69.1584 (2017).","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"60728_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41591-021-01600-6","volume":"28","author":"T Powles","year":"2022","unstructured":"Powles, T. et al. Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial. Nat. Med. 28 (1), 144\u2013153. https:\/\/doi.org\/10.1038\/s41591-021-01600-6 (2022).","journal-title":"Nat. Med."},{"issue":"6","key":"60728_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s13205-013-0117-5","volume":"3","author":"K Priya Batra, Anil","year":"2013","unstructured":"Priya Batra, Anil, K. & Sharma Anti-cancer potential of flavonoids: recent trends and future perspectives. 3 Biotech. 3 (6), 439\u2013459. https:\/\/doi.org\/10.1007\/s13205-013-0117-5 (2013).","journal-title":"3 Biotech."},{"key":"60728_CR15","doi-asserted-by":"publisher","first-page":"2696350","DOI":"10.1155\/2020\/2696350","volume":"2020","author":"ZY Lin","year":"2020","unstructured":"Lin, Z. Y., Lin, Y. Y., Shen, J. X., Jiang, M. J. & Hou, Y. M. Flavonoids in Ageratum conyzoides L. Exert Potent Antitumor Effects on Human Cervical Adenocarcinoma HeLa Cells In Vitro and In Vivo. Biomed. Res. Int. 2020, 2696350. https:\/\/doi.org\/10.1155\/2020\/2696350 (2020).","journal-title":"Biomed. Res. Int."},{"issue":"04","key":"60728_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.16007\/j.cnki.issn2095-7122.2022.04.008","volume":"35","author":"ZY Lin","year":"2022","unstructured":"Lin, Z. Y. et al. Antioxidant and Anticancer Activities of Total Flavonoids from Ageratum conyzoides. J. Minnan Normal Univ. (Natural Science). 35 (04), 65\u201371. https:\/\/doi.org\/10.16007\/j.cnki.issn2095-7122.2022.04.008 (2022).","journal-title":"J. Minnan Normal Univ. (Natural Science)"},{"issue":"14","key":"60728_CR17","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.phymed.2013.07.002","volume":"20","author":"ST Lee","year":"2013","unstructured":"Lee, S. T., Wong, P. F., Hooper, J. D. & Mustafa, M. R. Alpha-tomatine synergises with paclitaxel to enhance apoptosis of androgen-independent human prostate cancer PC-3 cells in vitro and in vivo. Phytomedicine 20 (14), 1297\u20131305. https:\/\/doi.org\/10.1016\/j.phymed.2013.07.002 (2013).","journal-title":"Phytomedicine"},{"key":"60728_CR18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.gene.2018.11.049","volume":"687","author":"Z\u00d6 Do\u011fan \u015ei\u011fva","year":"2019","unstructured":"Do\u011fan \u015ei\u011fva, Z. \u00d6. et al. Investigation of the synergistic effects of paclitaxel and herbal substances and endemic plant extracts on cell cycle and apoptosis signal pathways in prostate cancer cell lines. Gene 687, 261\u2013271. https:\/\/doi.org\/10.1016\/j.gene.2018.11.049 (2019).","journal-title":"Gene"},{"issue":"18","key":"60728_CR19","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1091\/mbc.E14-04-0916","volume":"25","author":"BA Weaver","year":"2014","unstructured":"Weaver, B. A. How Taxol\/paclitaxel kills cancer cells. Mol. Biol. Cell. 25 (18), 2677\u20132681. https:\/\/doi.org\/10.1091\/mbc.E14-04-0916 (2014).","journal-title":"Mol. Biol. Cell."},{"issue":"2","key":"60728_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3390\/nu12020457","volume":"12","author":"DM Kopustinskiene","year":"2020","unstructured":"Kopustinskiene, D. M., Jakstas, V., Savickas, A. & Bernatoniene, J. Flavonoids as Anticancer Agents Nutrients 12(2):457. doi: https:\/\/doi.org\/10.3390\/nu12020457. (2020).","journal-title":"Flavonoids as Anticancer Agents Nutrients"},{"key":"60728_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fgene.2015.00157","volume":"6","author":"A Torgovnick","year":"2015","unstructured":"Torgovnick, A. & Schumacher, B. DNA repair mechanisms in cancer development and therapy. Front. Genet. 6, 157. https:\/\/doi.org\/10.3389\/fgene.2015.00157 (2015).","journal-title":"Front. Genet."},{"issue":"1","key":"60728_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ncb2897","volume":"16","author":"MK Zeman","year":"2014","unstructured":"Zeman, M. K. & Cimprich, K. A. Causes and consequences of replication stress. Nat. Cell. Biol. 16 (1), 2\u20139. https:\/\/doi.org\/10.1038\/ncb2897 (2014).","journal-title":"Nat. Cell. Biol."},{"issue":"7","key":"60728_CR23","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1158\/1535-7163.803.3.7","volume":"3","author":"D Deeb","year":"2004","unstructured":"Deeb, D. et al. Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand\/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation. Mol. Cancer Ther. 3 (7), 803\u2013812 (2004).","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"60728_CR24","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi, L. et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell. Death Differ. 25 (3), 486\u2013541. https:\/\/doi.org\/10.1038\/s41418-017-0012-4 (2018).","journal-title":"Cell. Death Differ."},{"issue":"2","key":"60728_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell, B. R. et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell 171 (2), 273\u2013285. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021 (2017).","journal-title":"Cell"},{"issue":"4","key":"60728_CR26","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang, X., Stockwell, B. R. & Conrad, M. Ferroptosis: mechanisms, biology and role in disease. Nat. Rev. Mol. Cell. Biol. 22 (4), 266\u2013282. https:\/\/doi.org\/10.1038\/s41580-020-00324-8 (2021).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"5","key":"60728_CR27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen, X., Kang, R., Kroemer, G. & Tang, D. Broadening horizons: the role of ferroptosis in cancer. Nat. Rev. Clin. Oncol. 18 (5), 280\u2013296. https:\/\/doi.org\/10.1038\/s41571-020-00462-0 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"60728_CR28","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia, B., Vandenabeele, P. & Vanden Berghe, T. Targeting ferroptosis to iron out cancer. Cancer Cell. 35 (6), 830\u2013849. https:\/\/doi.org\/10.1016\/j.ccell.2019.04.002 (2019).","journal-title":"Cancer Cell."},{"issue":"1\u20132","key":"60728_CR29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang, W. S. et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 156 (1\u20132), 317\u2013331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010 (2014).","journal-title":"Cell"},{"issue":"6","key":"60728_CR30","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1158\/0008-5472.CAN-20-3477","volume":"81","author":"A Ghoochani","year":"2021","unstructured":"Ghoochani, A. et al. Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer. Cancer Res. 81 (6), 1583\u20131594. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-3477 (2021).","journal-title":"Cancer Res."},{"issue":"2","key":"60728_CR31","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou, T. C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 70 (2), 440\u2013446. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1947 (2010).","journal-title":"Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60728-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60728-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60728-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:33:38Z","timestamp":1791498818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60728-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60728"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60728-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31532"}}